European institutions and capitals divided over how far to push back against Washington without hurting Ukraine ...

The European Union’s chief trade negotiator said he would defend the bloc’s technology rules in a rebuke to US efforts to ...

A Reuters reporter created ads promising unrealistic investment returns and easily placed them on Meta's social media ...

Global power is increasingly being transferred from politicians to tech companies and their owners, Britain’s new spy chief ...

Discover how falling rates, Fed forecasts, and AI infrastructure growth will impact asset prices and investment strategies ...

Billions in AI bets, a government-backed lifeline, and a CEO with deep venture connections are pulling Intel in a new ...

For 3Q25, Macquarie Core Equity Fund Institutional Class shares underperformed the Fund’s benchmark, the S&P 500 Index. Read ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

Emails obtained by DeSmog show county officials continually met privately with Project Sail lobbyists, something denied to ...

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

By the end of 2025, calls on Tesla’s (TSLA) stock tell a now-familiar story. On one side are the bulls — including Wedbush star analyst Dan Ives — who say Tesla should no longer be valued primarily as ...

Limited editions, seasonal drops and recognisable themes could keep rings in the conversation between hardware cycles. If ...